FORDYCE MARSHALL (President and CEO) sold 18.4% of their position (19.38K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $929.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
+6.58K
Price / share
$2.90
Trade value
$19.06K
% of position
Class A Common Stock
Shares
−6.58K
Price / share
$47.05
Trade value
$309.53K
% of position
Class A Common Stock
Shares
+7.67K
Price / share
$2.90
Trade value
$22.20K
% of position
Class A Common Stock
Shares
−7.67K
Price / share
$48.18
Trade value
$369.33K
% of position
Class A Common Stock
Shares
+1.38K
Price / share
$2.90
Trade value
$4K
% of position
Class A Common Stock
Shares
−1.38K
Price / share
$48.80
Trade value
$67.40K
% of position
Class A Common Stock
Shares
+1.88K
Price / share
$2.90
Trade value
$5.43K
% of position
Class A Common Stock
Shares
−1.88K
Price / share
$48.76
Trade value
$91.42K
% of position
Class A Common Stock
Shares
+1.88K
Price / share
$2.90
Trade value
$5.43K
% of position
Class A Common Stock
Shares
−1.88K
Price / share
$49.00
Trade value
$91.88K
% of position
Net shares
+0.00
Net value
-$873.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/25/2024 | M · Option Exercise | +6.58K | $2.90 | $19.06K | 7.7% | 85.94K | 92.52K |
| Class A Common Stock Direct | 11/25/2024 | S · Sale | −6.58K | $47.05 | $309.53K | 7.1% | 92.52K | 85.94K |
| Class A Common Stock Direct | 11/25/2024 | M · Option Exercise | +7.67K | $2.90 | $22.20K | 8.9% | 85.94K | 93.61K |
| Class A Common Stock Direct | 11/25/2024 | S · Sale | −7.67K | $48.18 | $369.33K | 8.2% | 93.61K | 85.94K |
| Class A Common Stock Direct | 11/25/2024 | M · Option Exercise | +1.38K | $2.90 | $4K | 1.6% | 85.94K | 87.32K |
| Class A Common Stock Direct | 11/25/2024 | S · Sale | −1.38K | $48.80 | $67.40K | 1.6% | 87.32K | 85.94K |
| Class A Common Stock Direct | 11/25/2024 | M · Option Exercise | +1.88K | $2.90 | $5.43K | 2.2% | 85.94K | 87.82K |
| Class A Common Stock Direct | 11/25/2024 | S · Sale | −1.88K | $48.76 | $91.42K | 2.1% | 87.82K | 85.94K |
| Class A Common Stock Direct | 11/25/2024 | M · Option Exercise | +1.88K | $2.90 | $5.43K | 2.2% | 85.94K | 87.82K |
| Class A Common Stock Direct | 11/25/2024 | S · Sale | −1.88K | $49.00 | $91.88K | 2.1% | 87.82K | 85.94K |
| Total | +0.00 | -$873.43K | ||||||
Stock Option (Right to Buy)
Class A Common Stock
15.63K shares
Shares
−15.63K
Strike price
2.8968
Held after
722.96K
Exercisable
—
Stock Option (Right to Buy)
Class A Common Stock
1.88K shares
Shares
−1.88K
Strike price
2.8968
Held after
721.09K
Exercisable
—
Stock Option (Right to Buy)
Class A Common Stock
1.88K shares
Shares
−1.88K
Strike price
2.8968
Held after
719.21K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock15.63K shares | 11/25/2024 | M · Option Exercise | −15.63K | 2.8968 | — | 722.96K |
| Stock Option (Right to Buy) Direct | Class A Common Stock1.88K shares | 11/25/2024 | M · Option Exercise | −1.88K | 2.8968 | — | 721.09K |
| Stock Option (Right to Buy) Direct | Class A Common Stock1.88K shares | 11/25/2024 | M · Option Exercise | −1.88K | 2.8968 | — | 719.21K |
Class A Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 222.03K | Indirect |
| Total | 222.03K | 222.03K indirect |